Prelude Therapeutics Inc (PRLD)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch PRLD
See up to 3 months of PRLD. The 7-day demo opens the 1M and 3M ranges and puts PRLD on your watchlist.
Start 7-day demoLatest PRLD insider trades
About Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc is an SEC registrant, filing under CIK 0001678660, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
PRLD Form 4 activity by transaction type, last 90 days
No Form 4 activity for PRLD in the last 90 days.
PRLD insider transactions (Form 4)
3925 Form 4 filings on record, the earliest from Oct 7, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Option (right to buy) | 38,000 footnote F1 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Option (right to buy) | 38,000 footnote F1 | $0.00 | - | |
| ||||||
| Katina Dorton | Grant or award | Director Stock Option (Right to Buy) | 38,000 | $0.00 | - | |
| Martin Babler | Grant or award | Director Stock Option (Right to Buy) | 38,000 | $0.00 | - | |
| David P. Bonita | Grant or award | Director Stock Option (Right to Buy) | 38,000 | $0.00 | - | |
| Victor Sandor | Grant or award | Director Stock Option (Right to Buy) | 38,000 | $0.00 | - | |
| Paul A. Friedman | Grant or award | Director Stock Option (Right to Buy) | 38,000 | $0.00 | - | |
| Charles Q. Morris - Officer | Grant or award | Employee Stock Option (right to buy) | 450,000 | $4.70 | $2.12M | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Common Stock | 1,407,000 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Pre-Funded Warrants (Right to Buy) | 1,407,000 | - footnote F1 | - | |
| ||||||
| David P. Bonita - Director | Open-market purchase | Common Stock | 1,689,189 footnote F1 | $4.44 | $7.50M | |
| David P. Bonita - Director | Open-market purchase | Common Stock | 1,126,126 footnote F1 | $4.44 | $5.00M | |
| ||||||
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Common Stock | 1,689,189 footnote F1 | $4.44 | $7.50M | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Common Stock | 1,126,126 footnote F1 | $4.44 | $5.00M | |
| ||||||
| BAKER BROS. ADVISORS LP | Open-market purchase | Warrants to purchase Common Stock | 114,601 footnote F1 | $4.44 | $509K | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Warrants to purchase Common Stock | 2,137,651 footnote F1 | $4.44 | $9.49M | |
| ||||||
| Andrew Combs - Officer | Grant or award | Employee Stock Option (right to buy) | 230,000 | $0.00 | - | |
| Peggy Scherle - Officer | Grant or award | Employee Stock Option (right to buy) | 230,000 | $0.00 | - | |
| Bryant David Lim - Officer | Grant or award | Employee Stock Option (right to buy) | 275,000 | $0.00 | - | |
| Krishna Vaddi - Officer | Grant or award | Employee Stock Option (right to buy) | 837,000 | $0.00 | - | |
| Victor Sandor | Grant or award | Director Stock Option (Right to Buy) | 121,285 | $0.00 | - | |
| Katina Dorton | Grant or award | Director Stock Option (Right to Buy) | 76,000 | $0.00 | - | |
 Jane Huang - Officer | Option exercise | Common Stock | 9,375 | - footnote F1 | - | |
| Jane Huang - Officer | Tax withholding / forfeiture | Common Stock | 3,355 footnote F2 | $1.47 | $5K | |
| Jane Huang - Officer | Option exercise | Restricted Stock Unit | 9,375 | $0.00 | - | |
| ||||||
| Jane Huang - Officer | Option exercise | Common Stock | 9,375 | - | - | |
| Jane Huang - Officer | Tax withholding / forfeiture | Common Stock | 3,355 | $0.79 | $3K | |
| Jane Huang - Officer | Option exercise | Restricted Stock Unit | 9,375 | $0.00 | - | |
| Paul A. Friedman | Grant or award | Director Stock Option (Right to Buy) | 38,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 76,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 76,000 | $0.00 | - | |
| Andrew Combs - Officer | Open-market purchase | Common Stock | 3,075 | $1.15 | $4K | |
| Andrew Combs - Officer | Open-market purchase | Common Stock | 60,000 | $1.37 | $82K | |
| Bryant David Lim - Officer | Open-market purchase | Common Stock | 25,000 | $0.91 | $23K | |
| Krishna Vaddi - Officer | Open-market purchase | Common Stock | 100,000 | $0.93 | $93K | |
| Krishna Vaddi - Officer | Open-market purchase | Common Stock | 6,888 | $0.89 | $6K | |
| Jane Huang - Officer | Option exercise | Common Stock | 9,375 | - | - | |
| Jane Huang - Officer | Tax withholding / forfeiture | Common Stock | 3,349 | $2.00 | $7K | |
| Jane Huang - Officer | Option exercise | Restricted Stock Unit | 9,375 | $0.00 | - | |
Item 7.01, 9.01
Item 2.02, 9.01
Item 5.07
Item 2.02, 7.01, 9.01
PRLD insider trading FAQ
What is the latest insider trade for PRLD?
Prelude Therapeutics Inc (PRLD) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-10. The full record for PRLD runs to 25 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PRLD stock?
No insider purchases of PRLD were filed in the last 90 days. 11 purchases are on record for this company.
How many insiders are selling PRLD stock?
No insider sales of PRLD were filed in the last 90 days.
Where can I see PRLD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PRLD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - BAKER BROS. ADVISORS LP view on EDGAR
- - Katina Dorton view on EDGAR
- - Martin Babler view on EDGAR
- - David P. Bonita view on EDGAR
- - Victor Sandor view on EDGAR
- - Paul A. Friedman view on EDGAR
- - Charles Q. Morris view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - David P. Bonita view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PRLD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PRLD with a 7-day demo
- PRLD on your watchlist
- Every PRLD Form 4 filing on record
- Up to 3 months of PRLD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
